Merck & Co., Inc. — Director's Dealing 2019

Feb 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-02-12

Reporting Person: Chattopadhyay Sanat (Exe V-P & Pres. MMD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-12	Common Stock	M	43876.0000	$39.2900	Acquired	95343.0800	Direct
2019-02-12	Common Stock	M	29851.0000	$36.5600	Acquired	125194.0800	Direct
2019-02-12	Common Stock	S	73727.0000	$78.6185	Disposed	51467.0800	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-12	Stock Option (right to buy)	$39.2900	M	43876.0000	Disposed	2022-05-01	Common Stock (43876.0000)	Direct
2019-02-12	Stock Option (right to buy)	$36.5600	M	29851.0000	Disposed	2021-05-03	Common Stock (29851.0000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.5700 to $78.6900, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.

F4: The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014.